発作性上室頻拍の世界市場（～2026年）

• 英文タイトル：Global Paroxysmal Supraventricular Tachycardia Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04166
• 出版社/出版日：QYResearch / 2020年11月20日
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥561,600 (USD3,900)	▷ お問い合わせ
Multi User	￥842,400 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,123,200 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は発作性上室頻拍のグローバル市場について調査・分析したレポートです。種類別（電気生理学的研究（EPS）、ストレステスト、心臓カテーテル検査、冠動脈造影、心電図（ECG）、心エコー検査、ホルターモニター、イベントモニター、埋め込み型モニター、ラボテスト）市場規模、用途別（病院・診療所、診断センター、医学研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別発作性上室頻拍の競争状況、市場シェア
・世界の発作性上室頻拍市場：種類別市場規模 2015年-2020年（電気生理学的研究（EPS）、ストレステスト、心臓カテーテル検査、冠動脈造影、心電図（ECG）、心エコー検査、ホルターモニター、イベントモニター、埋め込み型モニター、ラボテスト）
・世界の発作性上室頻拍市場：種類別市場規模予測 2021年-2026年（電気生理学的研究（EPS）、ストレステスト、心臓カテーテル検査、冠動脈造影、心電図（ECG）、心エコー検査、ホルターモニター、イベントモニター、埋め込み型モニター、ラボテスト）
・世界の発作性上室頻拍市場：用途別市場規模 2015年-2020年（病院・診療所、診断センター、医学研究センター）
・世界の発作性上室頻拍市場：用途別市場規模予測 2021年-2026年（病院・診療所、診断センター、医学研究センター）
・北米の発作性上室頻拍市場分析：米国、カナダ
・ヨーロッパの発作性上室頻拍市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの発作性上室頻拍市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の発作性上室頻拍市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの発作性上室頻拍市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：GlaxoSmithKline、Sanofi、Pfizer、Novartis International、Teva Pharmaceutical Industries、Medtronic、Glenmark Pharmaceuticals、Abbott、Boston Scientific
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Paroxysmal supraventricular tachycardia (PSVT) is a type of supraventricular tachycardia. Often people have no symptoms. Otherwise symptoms may include palpitations, feeling lightheaded, sweating, shortness of breath, and chest pain. Episodes start and end suddenly.
About 2.3 per 1000 people have paroxysmal supraventricular tachycardia. Problems typically begin in those 12 to 45 years old. Women are more often affected than men. Outcomes in those who otherwise have a normal heart are generally good. An ultrasound of the heart may be done to rule out underlying heart problems.

Market Analysis and Insights: Global Paroxysmal Supraventricular Tachycardia Market
The global Paroxysmal Supraventricular Tachycardia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Paroxysmal Supraventricular Tachycardia Scope and Market Size
Paroxysmal Supraventricular Tachycardia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paroxysmal Supraventricular Tachycardia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
Sanofi
Pfizer
Novartis International
Teva Pharmaceutical Industries
Medtronic
Glenmark Pharmaceuticals
Abbott
Boston Scientific

Market segment by Type, the product can be split into
Electrophysiology Study (EPS)
Stress Test
Cardiac Catheterization
Coronary Angiography
Electrocardiogram (ECG)
Echocardiogram
Holter Monitor
Event Monitor
Implantable Monitor
Lab Tests
Market segment by Application, split into
Hospitals & Clinics
Diagnostic Centers
Medical Research Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Paroxysmal Supraventricular Tachycardia Revenue
1.4 Market by Type
1.4.1 Global Paroxysmal Supraventricular Tachycardia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Electrophysiology Study (EPS)
1.4.3 Stress Test
1.4.4 Cardiac Catheterization
1.4.5 Coronary Angiography
1.4.6 Electrocardiogram (ECG)
1.4.7 Echocardiogram
1.4.8 Holter Monitor
1.4.9 Event Monitor
1.4.10 Implantable Monitor
1.4.11 Lab Tests
1.5 Market by Application
1.5.1 Global Paroxysmal Supraventricular Tachycardia Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Diagnostic Centers
1.5.4 Medical Research Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Paroxysmal Supraventricular Tachycardia Market Perspective (2015-2026)
2.2 Global Paroxysmal Supraventricular Tachycardia Growth Trends by Regions
2.2.1 Paroxysmal Supraventricular Tachycardia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Paroxysmal Supraventricular Tachycardia Historic Market Share by Regions (2015-2020)
2.2.3 Paroxysmal Supraventricular Tachycardia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Paroxysmal Supraventricular Tachycardia Market Growth Strategy
2.3.6 Primary Interviews with Key Paroxysmal Supraventricular Tachycardia Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Paroxysmal Supraventricular Tachycardia Players by Market Size
3.1.1 Global Top Paroxysmal Supraventricular Tachycardia Players by Revenue (2015-2020)
3.1.2 Global Paroxysmal Supraventricular Tachycardia Revenue Market Share by Players (2015-2020)
3.1.3 Global Paroxysmal Supraventricular Tachycardia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Paroxysmal Supraventricular Tachycardia Market Concentration Ratio
3.2.1 Global Paroxysmal Supraventricular Tachycardia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Paroxysmal Supraventricular Tachycardia Revenue in 2019
3.3 Paroxysmal Supraventricular Tachycardia Key Players Head office and Area Served
3.4 Key Players Paroxysmal Supraventricular Tachycardia Product Solution and Service
3.5 Date of Enter into Paroxysmal Supraventricular Tachycardia Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Paroxysmal Supraventricular Tachycardia Historic Market Size by Type (2015-2020)
4.2 Global Paroxysmal Supraventricular Tachycardia Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)
5.2 Global Paroxysmal Supraventricular Tachycardia Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Paroxysmal Supraventricular Tachycardia Market Size (2015-2020)
6.2 Paroxysmal Supraventricular Tachycardia Key Players in North America (2019-2020)
6.3 North America Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020)
6.4 North America Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)

7 Europe
7.1 Europe Paroxysmal Supraventricular Tachycardia Market Size (2015-2020)
7.2 Paroxysmal Supraventricular Tachycardia Key Players in Europe (2019-2020)
7.3 Europe Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020)
7.4 Europe Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)

8 China
8.1 China Paroxysmal Supraventricular Tachycardia Market Size (2015-2020)
8.2 Paroxysmal Supraventricular Tachycardia Key Players in China (2019-2020)
8.3 China Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020)
8.4 China Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)

9 Japan
9.1 Japan Paroxysmal Supraventricular Tachycardia Market Size (2015-2020)
9.2 Paroxysmal Supraventricular Tachycardia Key Players in Japan (2019-2020)
9.3 Japan Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020)
9.4 Japan Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Paroxysmal Supraventricular Tachycardia Market Size (2015-2020)
10.2 Paroxysmal Supraventricular Tachycardia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020)
10.4 Southeast Asia Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)

11 India
11.1 India Paroxysmal Supraventricular Tachycardia Market Size (2015-2020)
11.2 Paroxysmal Supraventricular Tachycardia Key Players in India (2019-2020)
11.3 India Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020)
11.4 India Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Paroxysmal Supraventricular Tachycardia Market Size (2015-2020)
12.2 Paroxysmal Supraventricular Tachycardia Key Players in Central & South America (2019-2020)
12.3 Central & South America Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020)
12.4 Central & South America Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Paroxysmal Supraventricular Tachycardia Introduction
13.1.4 GlaxoSmithKline Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview
13.2.3 Sanofi Paroxysmal Supraventricular Tachycardia Introduction
13.2.4 Sanofi Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Paroxysmal Supraventricular Tachycardia Introduction
13.3.4 Pfizer Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novartis International
13.4.1 Novartis International Company Details
13.4.2 Novartis International Business Overview
13.4.3 Novartis International Paroxysmal Supraventricular Tachycardia Introduction
13.4.4 Novartis International Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.4.5 Novartis International Recent Development
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Details
13.5.2 Teva Pharmaceutical Industries Business Overview
13.5.3 Teva Pharmaceutical Industries Paroxysmal Supraventricular Tachycardia Introduction
13.5.4 Teva Pharmaceutical Industries Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.5.5 Teva Pharmaceutical Industries Recent Development
13.6 Medtronic
13.6.1 Medtronic Company Details
13.6.2 Medtronic Business Overview
13.6.3 Medtronic Paroxysmal Supraventricular Tachycardia Introduction
13.6.4 Medtronic Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.6.5 Medtronic Recent Development
13.7 Glenmark Pharmaceuticals
13.7.1 Glenmark Pharmaceuticals Company Details
13.7.2 Glenmark Pharmaceuticals Business Overview
13.7.3 Glenmark Pharmaceuticals Paroxysmal Supraventricular Tachycardia Introduction
13.7.4 Glenmark Pharmaceuticals Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.7.5 Glenmark Pharmaceuticals Recent Development
13.8 Abbott
13.8.1 Abbott Company Details
13.8.2 Abbott Business Overview
13.8.3 Abbott Paroxysmal Supraventricular Tachycardia Introduction
13.8.4 Abbott Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.8.5 Abbott Recent Development
13.9 Boston Scientific
13.9.1 Boston Scientific Company Details
13.9.2 Boston Scientific Business Overview
13.9.3 Boston Scientific Paroxysmal Supraventricular Tachycardia Introduction
13.9.4 Boston Scientific Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020)
13.9.5 Boston Scientific Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Paroxysmal Supraventricular Tachycardia Key Market Segments
Table 2. Key Players Covered: Ranking by Paroxysmal Supraventricular Tachycardia Revenue
Table 3. Ranking of Global Top Paroxysmal Supraventricular Tachycardia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Paroxysmal Supraventricular Tachycardia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Electrophysiology Study (EPS)
Table 6. Key Players of Stress Test
Table 7. Key Players of Cardiac Catheterization
Table 8. Key Players of Coronary Angiography
Table 9. Key Players of Electrocardiogram (ECG)
Table 10. Key Players of Echocardiogram
Table 11. Key Players of Holter Monitor
Table 12. Key Players of Event Monitor
Table 13. Key Players of Implantable Monitor
Table 14. Key Players of Lab Tests
Table 15. Global Paroxysmal Supraventricular Tachycardia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Paroxysmal Supraventricular Tachycardia Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Paroxysmal Supraventricular Tachycardia Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Paroxysmal Supraventricular Tachycardia Market Share by Regions (2015-2020)
Table 19. Global Paroxysmal Supraventricular Tachycardia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Paroxysmal Supraventricular Tachycardia Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Paroxysmal Supraventricular Tachycardia Market Growth Strategy
Table 25. Main Points Interviewed from Key Paroxysmal Supraventricular Tachycardia Players
Table 26. Global Paroxysmal Supraventricular Tachycardia Revenue by Players (2015-2020) (Million US$)
Table 27. Global Paroxysmal Supraventricular Tachycardia Market Share by Players (2015-2020)
Table 28. Global Top Paroxysmal Supraventricular Tachycardia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paroxysmal Supraventricular Tachycardia as of 2019)
Table 29. Global Paroxysmal Supraventricular Tachycardia by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Paroxysmal Supraventricular Tachycardia Product Solution and Service
Table 32. Date of Enter into Paroxysmal Supraventricular Tachycardia Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 35. Global Paroxysmal Supraventricular Tachycardia Market Size Share by Type (2015-2020)
Table 36. Global Paroxysmal Supraventricular Tachycardia Revenue Market Share by Type (2021-2026)
Table 37. Global Paroxysmal Supraventricular Tachycardia Market Size Share by Application (2015-2020)
Table 38. Global Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 39. Global Paroxysmal Supraventricular Tachycardia Market Size Share by Application (2021-2026)
Table 40. North America Key Players Paroxysmal Supraventricular Tachycardia Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Paroxysmal Supraventricular Tachycardia Market Share (2019-2020)
Table 42. North America Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 43. North America Paroxysmal Supraventricular Tachycardia Market Share by Type (2015-2020)
Table 44. North America Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 45. North America Paroxysmal Supraventricular Tachycardia Market Share by Application (2015-2020)
Table 46. Europe Key Players Paroxysmal Supraventricular Tachycardia Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Paroxysmal Supraventricular Tachycardia Market Share (2019-2020)
Table 48. Europe Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Paroxysmal Supraventricular Tachycardia Market Share by Type (2015-2020)
Table 50. Europe Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Paroxysmal Supraventricular Tachycardia Market Share by Application (2015-2020)
Table 52. China Key Players Paroxysmal Supraventricular Tachycardia Revenue (2019-2020) (Million US$)
Table 53. China Key Players Paroxysmal Supraventricular Tachycardia Market Share (2019-2020)
Table 54. China Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 55. China Paroxysmal Supraventricular Tachycardia Market Share by Type (2015-2020)
Table 56. China Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 57. China Paroxysmal Supraventricular Tachycardia Market Share by Application (2015-2020)
Table 58. Japan Key Players Paroxysmal Supraventricular Tachycardia Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Paroxysmal Supraventricular Tachycardia Market Share (2019-2020)
Table 60. Japan Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Paroxysmal Supraventricular Tachycardia Market Share by Type (2015-2020)
Table 62. Japan Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Paroxysmal Supraventricular Tachycardia Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Paroxysmal Supraventricular Tachycardia Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Paroxysmal Supraventricular Tachycardia Market Share (2019-2020)
Table 66. Southeast Asia Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Paroxysmal Supraventricular Tachycardia Market Share by Type (2015-2020)
Table 68. Southeast Asia Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Paroxysmal Supraventricular Tachycardia Market Share by Application (2015-2020)
Table 70. India Key Players Paroxysmal Supraventricular Tachycardia Revenue (2019-2020) (Million US$)
Table 71. India Key Players Paroxysmal Supraventricular Tachycardia Market Share (2019-2020)
Table 72. India Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 73. India Paroxysmal Supraventricular Tachycardia Market Share by Type (2015-2020)
Table 74. India Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 75. India Paroxysmal Supraventricular Tachycardia Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Paroxysmal Supraventricular Tachycardia Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Paroxysmal Supraventricular Tachycardia Market Share (2019-2020)
Table 78. Central & South America Paroxysmal Supraventricular Tachycardia Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Paroxysmal Supraventricular Tachycardia Market Share by Type (2015-2020)
Table 80. Central & South America Paroxysmal Supraventricular Tachycardia Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Paroxysmal Supraventricular Tachycardia Market Share by Application (2015-2020)
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Product
Table 90. Sanofi Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 91. Sanofi Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Product
Table 95. Pfizer Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 96. Pfizer Recent Development
Table 97. Novartis International Company Details
Table 98. Novartis International Business Overview
Table 99. Novartis International Product
Table 100. Novartis International Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 101. Novartis International Recent Development
Table 102. Teva Pharmaceutical Industries Company Details
Table 103. Teva Pharmaceutical Industries Business Overview
Table 104. Teva Pharmaceutical Industries Product
Table 105. Teva Pharmaceutical Industries Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 106. Teva Pharmaceutical Industries Recent Development
Table 107. Medtronic Company Details
Table 108. Medtronic Business Overview
Table 109. Medtronic Product
Table 110. Medtronic Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 111. Medtronic Recent Development
Table 112. Glenmark Pharmaceuticals Company Details
Table 113. Glenmark Pharmaceuticals Business Overview
Table 114. Glenmark Pharmaceuticals Product
Table 115. Glenmark Pharmaceuticals Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 116. Glenmark Pharmaceuticals Recent Development
Table 117. Abbott Business Overview
Table 118. Abbott Product
Table 119. Abbott Company Details
Table 120. Abbott Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 121. Abbott Recent Development
Table 122. Boston Scientific Company Details
Table 123. Boston Scientific Business Overview
Table 124. Boston Scientific Product
Table 125. Boston Scientific Revenue in Paroxysmal Supraventricular Tachycardia Business (2015-2020) (Million US$)
Table 126. Boston Scientific Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paroxysmal Supraventricular Tachycardia Market Share by Type: 2020 VS 2026
Figure 2. Electrophysiology Study (EPS) Features
Figure 3. Stress Test Features
Figure 4. Cardiac Catheterization Features
Figure 5. Coronary Angiography Features
Figure 6. Electrocardiogram (ECG) Features
Figure 7. Echocardiogram Features
Figure 8. Holter Monitor Features
Figure 9. Event Monitor Features
Figure 10. Implantable Monitor Features
Figure 11. Lab Tests Features
Figure 12. Global Paroxysmal Supraventricular Tachycardia Market Share by Application: 2020 VS 2026
Figure 13. Hospitals & Clinics Case Studies
Figure 14. Diagnostic Centers Case Studies
Figure 15. Medical Research Centers Case Studies
Figure 16. Paroxysmal Supraventricular Tachycardia Report Years Considered
Figure 17. Global Paroxysmal Supraventricular Tachycardia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Paroxysmal Supraventricular Tachycardia Market Share by Regions: 2020 VS 2026
Figure 19. Global Paroxysmal Supraventricular Tachycardia Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Paroxysmal Supraventricular Tachycardia Market Share by Players in 2019
Figure 22. Global Top Paroxysmal Supraventricular Tachycardia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paroxysmal Supraventricular Tachycardia as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Paroxysmal Supraventricular Tachycardia Revenue in 2019
Figure 24. North America Paroxysmal Supraventricular Tachycardia Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Paroxysmal Supraventricular Tachycardia Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Paroxysmal Supraventricular Tachycardia Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Paroxysmal Supraventricular Tachycardia Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Paroxysmal Supraventricular Tachycardia Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Paroxysmal Supraventricular Tachycardia Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Paroxysmal Supraventricular Tachycardia Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed

以下、関連資料のご紹介

体位性頻脈症候群（POTS）治療の世界市場（～2026年）

Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04336 2020年11月20日 99Pages
当調査資料は体位性頻脈症候群（POTS）治療のグローバル市場について調査・分析したレポートです。種類別（一次フォーム、二次フォーム）市場規模、用途別（病院、診療所、外来外科センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

心臓アブレーションの世界市場（～2026年）

Global Cardiac Ablation Market Size, Status and Forecast 2020-2026
MRC2-11QY11256 2020年11月25日 99Pages
当調査資料は心臓アブレーションのグローバル市場について調査・分析したレポートです。種類別（不可逆エレクトロポレーション、HIFU、MRgFUS）市場規模、用途別（心不整脈、心房細動、頻脈、開腹手術）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

遺伝性疾患薬の世界市場（～2026年）

Global Genetic Disorders Drug Market Insights and Forecast to 2026
MRC2-11QY06749 2020年11月20日 114Pages
当調査資料は遺伝性疾患薬のグローバル市場について調査・分析したレポートです。種類別（嚢胞性線維症（CF）、デュシェンヌ型筋ジストロフィー（DMD）、リソソーム蓄積症（LSD）、発作性夜間ヘモグロビン尿症（PNH））市場規模、用途別（クリニック、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

心房細動薬の世界市場（～2026年）

Global Atrial Fibrillation Drugs Market Insights and Forecast to 2026
MRC2-11QY02728 2020年11月20日 146Pages
当調査資料は心房細動薬のグローバル市場について調査・分析したレポートです。種類別（抗不整脈薬、抗凝固薬）市場規模、用途別（発作性心房細動、持続性心房細動、長年の持続性心房細動）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

口周囲リジュベネーションの世界市場（～2026年）

Global Perioral Rejuvenations Market Size, Status and Forecast 2020-2026
MRC2-11QY04219 2020年11月20日 99Pages
当調査資料は口周囲リジュベネーションのグローバル市場について調査・分析したレポートです。種類別（自家脂肪注射、フィラー、ボツリヌス毒素）市場規模、用途別（審美的ボリューム回復、しわ減少、ほうれい線、マリオネットライン・垂直リチッド、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...

癜風治療の世界市場（～2026年）

Global Tinea Versicolor Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04855 2020年11月20日 92Pages
当調査資料は癜風治療のグローバル市場について調査・分析したレポートです。種類別（抗真菌性シャンプー、抗真菌性クリーム、医薬品、その他）市場規模、用途別（病院、皮膚科クリニック、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...

ペプチド代謝障害治療薬の世界市場（～2026年）

Global Peptide Based Metabolic Disorders Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04207 2020年11月20日 96Pages
当調査資料はペプチド代謝障害治療薬のグローバル市場について調査・分析したレポートです。種類別（エクセナチド、リラグルチド、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

線維肉腫治療の世界市場（～2026年）

Global Fibrosarcoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11943 2020年11月25日 95Pages
当調査資料は線維肉腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、手術、その他）市場規模、用途別（病院、クリニック、専門がん治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

EMS製品の世界市場（～2026年）

Global EMS Products Market Size, Status and Forecast 2020-2026
MRC2-11QY11809 2020年11月25日 91Pages
当調査資料はEMS製品のグローバル市場について調査・分析したレポートです。種類別（生命維持・緊急蘇生装置、患者監視システム、創傷ケア消耗品、患者取り扱い装置、感染管理用品、個人用保護具）市場規模、用途別（病院・外傷センター、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

ヒト化肝臓マウスモデルの世界市場（～2026年）

Global Humanized Liver Mice Models Market Size, Status and Forecast 2020-2026
MRC2-11QY12259 2020年11月25日 98Pages
当調査資料はヒト化肝臓マウスモデルのグローバル市場について調査・分析したレポートです。種類別（uPA/SCIDマウスモデル、FRGマウスモデル、TK-NOGマウスモデル、その他）市場規模、用途別（バイオエンジニアリング、メディカルエンジニアリング、その他）市場規模、地域別（北米、米国、カナダ、ヨーロ...

ベビームーブメントモニターの世界市場（～2026年） Baby movement monitors sense the movements of a baby such as or breathing and set off alarms in the absence of movements after a certain duration. The adoption of baby movement monitors is increasing worldwide due to the introduction of new formats with additional features. The increasing demand for…
体位性頻脈症候群（POTS）治療の世界市場（～2026年） Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change from lying to standing causes an abnormally large increase in heart rate. Postural orthostatic tachycardia syndrome treatment may include avoiding factors that bring on symptoms, increasing dietary salt and water, comp…
心臓カテーテル検査の世界市場（～2026年） Market Analysis and Insights: Global Heart Catheterization Market The global Heart Catheterization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heart Catheterization Scope and Market Size Heart Catheterization marke…
心臓エレクトロフィジオロジーマッピング・ナビゲーション・記録装置の世界市場（～2026年） Market Analysis and Insights: Global Cardiac Electrophysiology Mapping, Navigation and Recording Devices Market The global Cardiac Electrophysiology Mapping, Navigation and Recording Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% duri…
心臓イメージングの世界市場（～2026年） Cardiac imaging comprises intravascular ultrasound, echocardiogram and coronary catheterization. Intravascular ultrasound is an imaging technique carried out with the help of specially designed catheters attached to computerized ultrasound equipment to visualize the lumen and interior wall of blood …